Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma.

Wu X, Huang PY, Peng PJ, Lu LX, Han F, Wu SX, Hou X, Zhao HY, Huang Y, Fang WF, Zhao YY, Xue C, Hu ZH, Zhang J, Zhang JW, Ma YX, Liang WH, Zhao C, Zhang L.

Ann Oncol. 2013 Aug;24(8):2131-6. doi: 10.1093/annonc/mdt163. Epub 2013 May 9.

PMID:
23661293
2.

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

Zhang L, Zhao C, Peng PJ, Lu LX, Huang PY, Han F, Wu SX.

J Clin Oncol. 2005 Nov 20;23(33):8461-8. Epub 2005 Oct 17.

PMID:
16230677
3.
4.

Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.

Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ.

J Natl Cancer Inst. 2011 Dec 7;103(23):1761-70. doi: 10.1093/jnci/djr432. Epub 2011 Nov 4.

PMID:
22056739
5.

A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.

Chen YP, Wang ZX, Chen L, Liu X, Tang LL, Mao YP, Li WF, Lin AH, Sun Y, Ma J.

Ann Oncol. 2015 Jan;26(1):205-11. doi: 10.1093/annonc/mdu507. Epub 2014 Oct 29.

PMID:
25355717
6.

Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.

Zhang B, Hu Y, Xiong RH, Pan YF, Xu QL, Kong XY, Cai R, Chen QQ, Tang HY, Jiang W.

Oncotarget. 2017 Feb 21;8(8):14078-14088. doi: 10.18632/oncotarget.13285.

7.

Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial.

Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J.

Eur J Cancer. 2017 Apr;75:150-158. doi: 10.1016/j.ejca.2017.01.002. Epub 2017 Feb 22.

PMID:
28235726
8.

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J.

Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7.

PMID:
22154591
9.
10.

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.

Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, Lin AH, Zeng XF, Ma J.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1356-64. doi: 10.1016/j.ijrobp.2007.12.028. Epub 2008 May 9.

PMID:
18472356
11.

Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.

Li WF, Li YQ, Chen L, Zhang Y, Guo R, Zhang F, Peng H, Sun Y, Ma J.

BMC Cancer. 2015 Oct 27;15:810. doi: 10.1186/s12885-015-1768-x.

12.

Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience.

Chua DT, Sham JS, Choy D, Kwong DL, Au GK, Kwong PW, Yau CC, Cheng AC, Wan KY.

Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1219-28.

PMID:
11286826
13.

Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study.

Li SW, Wang H, Liu ML, Zhang HB, Xiang YQ, Lv X, Xia WX, Zeng MS, Mai HQ, Hong MH, Guo X.

Med Oncol. 2013 Mar;30(1):322. doi: 10.1007/s12032-012-0322-9. Epub 2012 Dec 15.

PMID:
23254962
14.

Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.

Zhang J, Chen S, Li G, Zhang W, Qin T, Yin P, Huang H, Jiang H.

Cancer Chemother Pharmacol. 2017 Jun;79(6):1087-1097. doi: 10.1007/s00280-017-3297-6. Epub 2017 Apr 20.

PMID:
28429051
16.

Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.

Sun X, Zeng L, Chen C, Huang Y, Han F, Xiao W, Liu S, Lu T.

Radiat Oncol. 2013 Nov 13;8:265. doi: 10.1186/1748-717X-8-265.

17.

Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.

Liang Z, Wang S, Lin Z, Feng S, Cheng Z, Yang Y, Kuang Y, Fidelis C, Ullah S, Li F.

Cancer Chemother Pharmacol. 2016 Mar;77(3):643-51. doi: 10.1007/s00280-016-2971-4. Epub 2016 Jan 30.

PMID:
26831498
19.

A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma.

Huang PY, Cao KJ, Guo X, Mo HY, Guo L, Xiang YQ, Deng MQ, Qiu F, Cao SM, Guo Y, Zhang L, Li NW, Sun R, Chen QY, Luo DH, Hua YJ, Mai HQ, Hong MH.

Oral Oncol. 2012 Oct;48(10):1038-1044. doi: 10.1016/j.oraloncology.2012.04.006. Epub 2012 May 14.

PMID:
22591726
20.

Chemotherapy in locoregionally advanced nasopharyngeal carcinoma-a review.

Krstevska V, Stojkovski I.

J BUON. 2008 Oct-Dec;13(4):495-503. Review.

PMID:
19145670

Supplemental Content

Support Center